Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 2:06 PM
Ignite Modification Date: 2025-12-25 @ 12:49 PM
NCT ID: NCT03274895
Description: None
Frequency Threshold: 2
Time Frame: 1 year
Study: NCT03274895
Study Brief: Polihexanide (PHMB) Eye Drops in Patients Affected by Acanthamoeba Keratitis
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
PHMB 0.08% Plus Placebo polihexanide (PHMB) 0.08% and placebo were administered in the affected eye until clinical resolution for a maximum of 12 months 0 None 0 69 31 69 View
PHMB 0.02% Plus Propamidine 0.1% polihexanide (PHMB) 0.02% and propamidine 0.1% were administered in the affected eye until clinical resolution for a maximum of 12 months 0 None 0 65 29 65 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
eye pain SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (Unspecified) View
ocular hyperemia SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (Unspecified) View
lacrimation increased SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (Unspecified) View
conjunctival hyperemia SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (Unspecified) View
eye irritation SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (Unspecified) View
photophobia SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (Unspecified) View
eye inflammation SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (Unspecified) View
corneal epithelium defect SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (Unspecified) View
eye pruritus SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (Unspecified) View
eye discharge SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (Unspecified) View
eye swelling SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (Unspecified) View
keratitis SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (Unspecified) View
ocular discomfort SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (Unspecified) View
corneal infiltrates SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (Unspecified) View